## **Core Concept**
Congenital heart block (CHB) in a fetus is often associated with maternal autoimmune diseases, particularly those involving the production of autoantibodies. The most common condition linked to CHB is maternal Sjögren's syndrome or systemic lupus erythematosus (SLE), where autoantibodies can cross the placenta and affect the fetal heart.

## **Why the Correct Answer is Right**
The correct answer, , involves evaluating the mother for the presence of **SSA/Ro** and **SSB/La** autoantibodies. These autoantibodies are strongly associated with an increased risk of congenital heart block in the fetus. The mechanism involves the transplacental passage of these autoantibodies, which then target the fetal heart, leading to inflammation and damage to the cardiac conduction system. This can result in various degrees of heart block, ranging from first-degree (partial) to third-degree (complete) heart block.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, while a general autoimmune workup might be considered, the specific and most relevant evaluation for CHB involves looking for **SSA/Ro** and **SSB/La** autoantibodies.
- **Option B:** This option does not directly relate to the specific autoantibodies known to cause CHB.
- **Option C:** This option might be considered in a broader differential for maternal conditions but is not the most directly relevant or specific evaluation for CHB.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that mothers who are **SSA/Ro** and **SSB/La** positive have a significantly increased risk of having a fetus with congenital heart block, and this risk can be as high as 2-5%. Screening for these autoantibodies in mothers with a history of autoimmune disease or with a fetus diagnosed with CHB is crucial.

## **Correct Answer:** . SSA/Ro and SSB/La antibodies.